Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
100%(10 trials)

Phase Distribution

Ph phase_3
9
82%
Ph not_applicable
1
9%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
9(81.8%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Other(1)

Detailed Status

Completed10
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 39 (81.8%)
N/A1 (9.1%)

Trials by Status

unknown19%
completed1091%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_3

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

NCT00255190
unknownnot_applicable

Dexlansoprazole MR in Nonerosive Reflux Disease

NCT02490449
completedphase_3

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00321737
completedphase_3

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

NCT00251693
completedphase_3

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

NCT00251719
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00255190Phase 3

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Completed
NCT02490449Not Applicable

Dexlansoprazole MR in Nonerosive Reflux Disease

Unknown
NCT00321737Phase 3

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Completed
NCT00251693Phase 3

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Completed
NCT00251719Phase 3

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Completed
NCT00255151Phase 3

Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

Completed
NCT00255164Phase 3

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Completed
NCT00847210Phase 1

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Completed
NCT00321984Phase 3

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Completed
NCT00251745Phase 3

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Completed
NCT00251758Phase 3

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11